Merck has announced the presentation of a new analysis of efficacy data for MAVENCLAD (cladribine tablets) for the treatment of patients with relapsing-remitting multiple sclerosis. …
Latest Video
Georgia Forrest
New Stories
-
The 'Dispatched' Week in Review Podcast - 6 February
February 6, 2026 - - Podcast -
AI in healthcare and why doing nothing might be the biggest risk
February 5, 2026 - - Latest News -
An effective example of making the case for reform in a status quo-biased system
February 5, 2026 - - Latest News -
Pharmac consults on expanding access to Takeda blood cancer therapy
February 5, 2026 - - Latest News -
GBMA moves to reclaim the reform agenda with a focus on pricing and supply
February 5, 2026 - - Latest News -
Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies
February 4, 2026 - - Latest News -
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 - - Latest News